These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Deficiency of oncoretrovirally transduced hematopoietic stem cells and correction through ex vivo expansion. Bryder D; Björgvinsdóttir H; Sasaki Y; Jacobsen SE J Gene Med; 2005 Feb; 7(2):137-44. PubMed ID: 15538726 [TBL] [Abstract][Full Text] [Related]
23. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation. Neschadim A; McCart JA; Keating A; Medin JA Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569 [TBL] [Abstract][Full Text] [Related]
24. [General principles of the production and use of retroviral vectors]. Lehn P Pathol Biol (Paris); 1993 Oct; 41(8):658-62. PubMed ID: 8290308 [TBL] [Abstract][Full Text] [Related]
25. Macrophages in gene therapy: cellular delivery vehicles and in vivo targets. Burke B; Sumner S; Maitland N; Lewis CE J Leukoc Biol; 2002 Sep; 72(3):417-28. PubMed ID: 12223508 [TBL] [Abstract][Full Text] [Related]
26. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID. Taupin P IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313 [TBL] [Abstract][Full Text] [Related]
27. Ex vivo expansion of hematopoietic cells and their clinical use. Aglietta M; Bertolini F; Carlo-Stella C; De Vincentiis A; Lanata L; Lemoli RM; Olivieri A; Siena S; Zanon P; Tura S Haematologica; 1998 Sep; 83(9):824-48. PubMed ID: 9825579 [TBL] [Abstract][Full Text] [Related]
29. Umbilical cord blood stem cells as targets for genetic modification: new therapeutic approaches to somatic gene therapy. Williams DA; Moritz T Blood Cells; 1994; 20(2-3):504-15; discussion 515-6. PubMed ID: 7749118 [TBL] [Abstract][Full Text] [Related]
30. The current status of gene therapy in autologous transplantation. Becker PS Acta Haematol; 2005; 114(4):188-97. PubMed ID: 16269858 [TBL] [Abstract][Full Text] [Related]
31. Genotoxicity of retroviral integration in hematopoietic cells. Nienhuis AW; Dunbar CE; Sorrentino BP Mol Ther; 2006 Jun; 13(6):1031-49. PubMed ID: 16624621 [TBL] [Abstract][Full Text] [Related]
32. A review of gene therapy for haematological disorders. Nathwani AC; Davidoff AM; Linch DC Br J Haematol; 2005 Jan; 128(1):3-17. PubMed ID: 15606545 [TBL] [Abstract][Full Text] [Related]
33. Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells. Plavec I; Voytovich A; Moss K; Webster D; Hanley MB; Escaich S; Ho KE; Böhnlein E; DiGiusto DL Gene Ther; 1996 Aug; 3(8):717-24. PubMed ID: 8854097 [TBL] [Abstract][Full Text] [Related]
34. [Recent developments in gene therapy]. Vandendriessche T Verh K Acad Geneeskd Belg; 2004; 66(4):305-17; discussion 317-20. PubMed ID: 15553101 [TBL] [Abstract][Full Text] [Related]
37. Gene transfer into hematopoietic stem cells: prospects for human gene therapy. Einerhand MP; Valerio D Curr Top Microbiol Immunol; 1992; 177():217-35. PubMed ID: 1353431 [No Abstract] [Full Text] [Related]
38. Medicine. Gene therapy--new challenges ahead. Williams DA; Baum C Science; 2003 Oct; 302(5644):400-1. PubMed ID: 14563994 [TBL] [Abstract][Full Text] [Related]
39. Retroviral gene transfer: applications to human therapy. Gilboa E Prog Clin Biol Res; 1990; 352():301-11. PubMed ID: 1698298 [No Abstract] [Full Text] [Related]
40. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning. Gaspar HB; Bjorkegren E; Parsley K; Gilmour KC; King D; Sinclair J; Zhang F; Giannakopoulos A; Adams S; Fairbanks LD; Gaspar J; Henderson L; Xu-Bayford JH; Davies EG; Veys PA; Kinnon C; Thrasher AJ Mol Ther; 2006 Oct; 14(4):505-13. PubMed ID: 16905365 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]